Copyright
©The Author(s) 2017.
World J Hepatol. Apr 8, 2017; 9(10): 491-502
Published online Apr 8, 2017. doi: 10.4254/wjh.v9.i10.491
Published online Apr 8, 2017. doi: 10.4254/wjh.v9.i10.491
Elements necessary for the diagnostic evaluation of DILI |
Known duration of exposure |
Concomitant medications and diseases |
Response to dechallenge (and rechallenge if performed) |
Presence or absence of symptoms, rash, eosinophilia |
Performing sufficient exclusionary tests (viral serology, imaging, etc.) to reflect the injury pattern and acuteness of liver function tests (e.g., acute viral serology for A, B and C and autoimmune hepatitis when presenting with acute hepatocellular injury; routine testing for hepatitis E virus not recommended because of the problems with current commercial assays; Epstein-Barr virus, cytomegalovirus, and other viral serology if lymphadenopathy, atypical lymphocytosis present) |
Sufficient time to determine clinical outcome - did the event resolve or become chronic? |
Use of liver biopsy |
Often not required if the acute injury resolves |
Helpful in confirming clinical suspicion of DILI but rarely pathognomonic |
Useful to differentiate between Drug-Induced autoimmune hepatitis and idiopathic autoimmune hepatitis |
Useful to rule out underlying chronic viral hepatitis, non-alcoholic fatty liver disease, alcoholic liver disease, or other chronic liver disease |
Used to exclude DILI where re-exposure or ongoing use of an agent is expected |
Rechallenge: Generally best avoided, unless there is no alternative treatment |
Use of Causality Assessment Methods |
Roussel Uclaf Causality Assessment Method is best considered an adjunct to expert opinion (it should not be the sole diagnostic method) |
Consensus opinion |
Expert consultation |
For patients with chronic viral hepatitis, DILI requires a high index of suspicion, knowledge of a stable clinical course before the new medication, and monitoring of viral loads to rule out flares of the underlying disease |
Assigning causality to herbal compounds and dietary supplements can be especially difficult; require knowledge of all ingredients and their purity |
- Citation: Alempijevic T, Zec S, Milosavljevic T. Drug-induced liver injury: Do we know everything? World J Hepatol 2017; 9(10): 491-502
- URL: https://www.wjgnet.com/1948-5182/full/v9/i10/491.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i10.491